ArticleJournal of cancer research and clinical oncology2023

Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer.

Yuankui Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.